Controlled release application of multilamellar vesicles: a novel drug delivery approach

References

• Agnihotri, S.A., Aminabhavi, T.M. (2004). Formulation and evaluation of novel tableted chitosan microparticles for the controlled release of clozapine. J Microencapsul. 21:709–18.
   PubMed Web of Science ®Google Scholar
• Baker, R.W., Lonsdale, H.K. (1974). Controlled release: mechanisms and rates. In: Tanquarry, A.C., Lacey, R.E., eds. Controlled release of biologically active agents. New York: Plenum Press, 15–71.
   Google Scholar
• Betageri, G.V. (1993). Liposomal encapsulation and stability of dideoxyinosine triphosphae. Drug Dev Ind Pharm. 19:531–9.
   Web of Science ®Google Scholar
• Betageri, G.V. (2004). Enteric-coated proliposomal formulations for poorly water soluble drugs. U.S. Patent. No. 6,759,058.
   Google Scholar
• Betageri, G.V. (2005). Proliposomal drug delivery system. U.S. Patent. No. 6,849,269.
   Google Scholar
• Betageri, G.V., Kulkarni, S.B. (1999). Preparation of liposomes. In: Arshady, R., ed. Microspheres, microcapsules and liposomes, Volume 1. London: Citus Books, 490–521.
   Google Scholar
• Betageri, G.V., Parsons, D.L. (1992). Drug encapsulation and release from multilamellar and unilamellar liposomes. Int J Pharm. 81:235–41.
   Web of Science ®Google Scholar
• Bodmeier, R. (1997). Tableting of coated pellets. Eur J Pharm Biopharm. 43:1–8.
   Web of Science ®Google Scholar
• Brocks, D.R., Betageri, G.V. (2002). Enhanced oral absorption of halofantrine enantiomers after encapsulation in a proliposomal formulation. J Pharm Pharmacol. 54:1049–53.
   PubMed Web of Science ®Google Scholar
• Chen, H.M., Torchilin, V., Langer, R. (1996). Polymerized liposomes as potential oral vaccine carriers: Stability and bioavailability. J Contr Rel. 42:263–72.
   Web of Science ®Google Scholar
• Deshmukh, D.D., Ravis, W.R., Betageri, G.V. (2008). Improved delivery of cromolyn from oral proliposomal beads. Int J Pharm. 358:128–36.
   PubMed Web of Science ®Google Scholar
• DiBiase, M.D., Morrel, E.M. (1997). Oral delivery of microencapsulated proteins. In: Sanders, L.M., Wayne Hendren, R., eds. Protein delivery: Physical systems. New York: Plenum Press, 255–88.
   Google Scholar
• Dipali, S.R., Kulkarni, S.B., Betageri, G.V. (1996). Comparative study of separation of non-encapsulated drug from unilamellar liposomes by various methods. J Pharm Pharmacol. 48:1112–5.
   PubMed Web of Science ®Google Scholar
• Elbayoumi, T.A., Torchilin, V.P. (2008). Tumor-specific antibody-mediated targeted delivery of Doxil® reduces the manifestation of auricular erythema side effect in mice. Int J Pharm. 357:272–9.
   PubMed Web of Science ®Google Scholar
• Florence, A.T. (1997). The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual. Pharm Res. 14:259–66.
   PubMed Web of Science ®Google Scholar
• Galeone, M., Nizzola, L., Cacioli, D., Mosie, G. (1981). In-vitro demonstration of delivery mechanism from sustained-release pellets. Curr Therap Res. 29:217–34.
   Web of Science ®Google Scholar
• Henriksen, I., Smistad, G., Karlsen, J. (1994). Interactions between liposomes and chitosan. Int J Pharm. 101:227–36.
   Web of Science ®Google Scholar
• Kulkarni, S.B., Betageri, G.V., Singh, M. (1995). Factors affecting microencapsulation of drugs in liposomes. J Microencapsul. 12:229–46.
   PubMed Web of Science ®Google Scholar
• Kumar, R., Gupta, R.B., Betageri, G.V. (2001). Formulation, characterization and in-vitro release of glyburide from proliposomal beads. Drug Deliv. 8:25–7.
   PubMed Web of Science ®Google Scholar
• Payne, N.I., Timmins, P., Ambrose, C.V., Ward, M.D., Ridgway, F. (1986). Proliposomes: a novel solution to an old problem. J Pharm Sci. 75:325–9.
   PubMed Web of Science ®Google Scholar
• Peppas, N.A. (1980). Mathematical modeling of diffusion process in drug delivery polymeric systems. In: Smolen, V.F., ed. Bioavailability and the pharmacokinetic control of drug response. New York: Wiley.
   Google Scholar
• Pitre, D., Stradi, R. (1982). Analytical profiles of drug substances. In: Florey, K., ed. Vol. 16. Orlando, FL: Academic Press, 327.
   Google Scholar
• Reynolds, J.R., ed. (1993). Martindale: The extra pharmacopoeia, 30th Ed. London: Pharmaceutical Press, 892–4.
   Google Scholar
• Ritger, P.L., Peppas, N.A. (1987). A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J Contr Rel. 5:37–42.
   Google Scholar
• Rogers, J.A., Anderson, K.E. (1998). The potential of liposomes in oral drug delivery. Crit Rev Ther Drug Carrier Sys. 15:465–524.
   Google Scholar
• Sabnis, S., Rege, P., Block, L.H. (1997). Use of chitosan in compressed tablets of diclofenac sodium: inhibition of drug release in an acidic environment. Pharm Dev Technol. 2:243–55.
   PubMedGoogle Scholar
• Soppimath, K.S., Betageri, G.V. (2008). Nanostructures for cancer therapy. In: Gonsalves, K.E., Halberstadt, C.G., Laurencin, C.T., Nair, L.S., eds. Biomedical nanostructures. New Jersey: John Wiley & Sons, 409–38.
   Google Scholar
• Sun, W.Q., Leopold, A.C., Crowe, L.M., Crowe, J.H. (1996). Stability of dry liposomes in sugar glasses. Biophys J. 70:1769–76.
   PubMed Web of Science ®Google Scholar
• Teng, L., Bruce, R.B., Dunning, L.K. (1977). Metaclopramide metabolism and determination by high-pressure liquid chromatography. J Pharm Sci. 66:1615–8.
   PubMed Web of Science ®Google Scholar
• Thongborissute, J., Takeuchi, H., Yamamoto, H., Kawashima, Y. (2006). Properties of liposomes coated with hydrophobically modified chitosan in oral liposomal drug delivery. Pharmazie. 61:106–11.
   PubMed Web of Science ®Google Scholar
• USP DI. (1998). Drug information for the health care professional. Vol. I, 18th Ed. United States Pharmacopoeial Convention, Rockville, 2009–13.
   Google Scholar